152 related articles for article (PubMed ID: 37976117)
1. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.
Alibaz-Öner F; Kelesoglu B; Balci MA; Yardimci GK; Armağan B; Kiliç L; Karakaş Ö; Erden A; Yasar Bilge S; Kardaş RC; Küçük H; Zengin O; Tasci M; Kocaer SB; Yavuz S; Dogru A; Şahin M; Bayindir O; Sevik G; Ertürk Z; Alpay-Kanitez N; Gogebakan H; Tezcan ME; Oksuz MF; Cefle A; Kucuksahin O; Yazici A; Kasapoglu E; Bes C; Unal AU; Dalkiliç E; Yildirim Çetin G; Aksu K; Keser G; Onen F; Çobankara V; Kisacik B; Onat AM; Öztürk MA; Kaşifoğlu T; Omma A; Karadag O; Ates A; Direskeneli H
Clin Exp Rheumatol; 2024 Apr; 42(4):816-821. PubMed ID: 37976117
[TBL] [Abstract][Full Text] [Related]
2. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
3. Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions.
Sugihara T; Hasegawa H; Uchida HA; Yoshifuji H; Watanabe Y; Amiya E; Maejima Y; Konishi M; Murakawa Y; Ogawa N; Furuta S; Katsumata Y; Komagata Y; Naniwa T; Okazaki T; Tanaka Y; Takeuchi T; Nakaoka Y; Arimura Y; Harigai M; Isobe M;
Arthritis Res Ther; 2020 Apr; 22(1):72. PubMed ID: 32264967
[TBL] [Abstract][Full Text] [Related]
4. [Management of polymyalgia rheumatica and large vessel vasculitis].
Hellmich B
Internist (Berl); 2016 Nov; 57(11):1069-1078. PubMed ID: 27631531
[TBL] [Abstract][Full Text] [Related]
5. The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis-study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study.
Kreis L; Dejaco C; Schmidt WA; Németh R; Venhoff N; Schäfer VS
Trials; 2024 Jan; 25(1):56. PubMed ID: 38225579
[TBL] [Abstract][Full Text] [Related]
6. Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center.
Öztaş M; Özgül H; Seyahi E; Uğurlu S
Turk J Med Sci; 2022 Aug; 52(4):917-925. PubMed ID: 36326373
[TBL] [Abstract][Full Text] [Related]
7. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
8. Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.
Kermani TA; Warrington KJ; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; McAlear CA; Monach PA; Seo P; Merkel PA; Ytterberg SR;
J Rheumatol; 2015 Jul; 42(7):1213-7. PubMed ID: 25877501
[TBL] [Abstract][Full Text] [Related]
9. Do Early Diagnosis and Glucocorticoid Treatment Decrease the Risk of Permanent Visual Loss and Early Relapses in Giant Cell Arteritis: A Prospective Longitudinal Study.
Hocevar A; Rotar Z; Jese R; Semrl SS; Pizem J; Hawlina M; Tomsic M
Medicine (Baltimore); 2016 Apr; 95(14):e3210. PubMed ID: 27057850
[TBL] [Abstract][Full Text] [Related]
10. Role of oral cyclophosphamide in the treatment of giant cell arteritis.
Quartuccio L; Maset M; De Maglio G; Pontarini E; Fabris M; Mansutti E; Mariuzzi L; Pizzolitto S; Beltrami CA; De Vita S
Rheumatology (Oxford); 2012 Sep; 51(9):1677-86. PubMed ID: 22627726
[TBL] [Abstract][Full Text] [Related]
11. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases.
Vinicki JP; García-Vicuña R; Arredondo M; López-Bote JP; García-Vadillo JA; Castañeda S; Álvaro-Gracia JM
Reumatol Clin; 2017; 13(4):210-213. PubMed ID: 27499427
[TBL] [Abstract][Full Text] [Related]
12. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
[TBL] [Abstract][Full Text] [Related]
13. Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review.
de Boysson H; Boutemy J; Creveuil C; Ollivier Y; Letellier P; Pagnoux C; Bienvenu B
Semin Arthritis Rheum; 2013 Aug; 43(1):105-12. PubMed ID: 23453684
[TBL] [Abstract][Full Text] [Related]
14. Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patients.
Ly KH; Dalmay F; Gondran G; Palat S; Bezanahary H; Cypierre A; Fauchais AL; Liozon E
Medicine (Baltimore); 2016 Oct; 95(42):e4974. PubMed ID: 27759628
[TBL] [Abstract][Full Text] [Related]
15. Treatment of giant cell arteritis.
González-Gay MÁ; Pina T; Prieto-Peña D; Calderon-Goercke M; Gualillo O; Castañeda S
Biochem Pharmacol; 2019 Jul; 165():230-239. PubMed ID: 31034796
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis.
Hachulla E; Boivin V; Pasturel-Michon U; Fauchais AL; Bouroz-Joly J; Perez-Cousin M; Hatron PY; Devulder B
Clin Exp Rheumatol; 2001; 19(2):171-6. PubMed ID: 11326479
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell Arteritis.
Dumont A; Parienti JJ; Delmas C; Boutemy J; Maigné G; Martin Silva N; Sultan A; Planchard G; Aouba A; de Boysson H
J Rheumatol; 2020 Jan; 47(1):108-116. PubMed ID: 30877210
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.
Koster MJ; Yeruva K; Crowson CS; Muratore F; Labarca C; Warrington KJ
J Rheumatol; 2019 May; 46(5):501-508. PubMed ID: 30647171
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.
Samson M; Devilliers H; Ly KH; Maurier F; Bienvenu B; Terrier B; Charles P; Guillevin L; Besancenot JF; Liozon E; Fauchais AL; Loffroy R; Binquet C; Audia S; Seror R; Mariette X; Bonnotte B
Eur J Intern Med; 2018 Nov; 57():96-104. PubMed ID: 30054122
[TBL] [Abstract][Full Text] [Related]
20. Body mass index associates with disease relapse in patients with giant cell arteritis.
Matsumoto K; Kaneko Y; Takeuchi T
Int J Rheum Dis; 2019 Sep; 22(9):1782-1786. PubMed ID: 31245915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
